Skip to main content
    B

    Bausch Health Companies Inc (BHC)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NYSE

    $8.43
    +0.07 (+0.90%)

    Market Cap: $3.13B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Bausch Health Companies Inc (BHC) Stock Forecast

    Updated Nov 17, 2026. Estimates and ratings come from consensus analyst data.

    Analysts expect Bausch Health Companies (BHC) to earn $4.91 per share in the fiscal year ending Dec 31, 2026, on revenue of $11.03B. Of 7 analysts, 0 rate the stock Buy or Strong Buy, 7 Hold and 0 Sell or Strong Sell, for a consensus of Hold. Over the last 30 days, 1 estimate for the fiscal year ending Dec 31, 2026 was revised up and 0 down.

    Analyst Ratings

    Scoring Strong Buy as 1 and Strong Sell as 5, the 7 ratings average 3.00, inside the Hold band from 2.5 up to 3.5. All 7 rate it Hold.

    RatingAnalystsShare
    Strong Buy00.0%
    Buy00.0%
    Hold7100.0%
    Sell00.0%
    Strong Sell00.0%
    Consensus
    Hold
    Total analysts
    7

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Annual Estimates

    From the first fiscal year below to the second, the EPS consensus falls 11.6% and revenue estimates fall 0.6%.

    Fiscal year ending Dec 31, 2026
    $4.91
    EPS consensus, revenue $11.03B
    Fiscal year ending Dec 31, 2027
    $4.34
    EPS consensus, revenue $10.96B

    EPS range

    Revenue range

    Fiscal year endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$4.91$4.32 to $5.336$11.03B$10.92B to $11.11B5
    Dec 31, 2027$4.34$4.00 to $4.776$10.96B$10.85B to $11.14B5

    Quarterly Estimates

    The EPS consensus falls from $1.39 for the quarter ending Dec 31, 2026 to $0.79 for the quarter ending Mar 31, 2027.

    EPS range

    Revenue range

    Quarter endingEPS consensusEPS rangeEPS analystsRevenue consensusRevenue rangeRev. analysts
    Dec 31, 2026$1.39$1.21 to $1.564$2.81B$2.72B to $2.93B4
    Mar 31, 2027$0.79$0.71 to $0.874$2.52B$2.50B to $2.54B2

    Estimate Revisions

    Across the 3 periods below, the last 30 days brought 3 upward and 1 downward EPS revisions.

    PeriodUp 30 daysDown 30 days
    Fiscal year ending Dec 31, 202610
    Fiscal year ending Dec 31, 202711
    Quarter ending Mar 31, 202710

    EPS Trend

    Over the last 90 days, the EPS consensus for the fiscal year ending Dec 31, 2026 has risen 9.8% from $4.47.

    PeriodNow7 days ago30 days ago60 days ago90 days agoChange
    Fiscal year ending Dec 31, 2026$4.91$4.79$4.47$4.47$4.47+9.8%
    Fiscal year ending Dec 31, 2027$4.34$4.31$4.19$4.19$4.19+3.5%
    Quarter ending Mar 31, 2027$0.79$0.82$0.82$0.82$0.82-3.0%

    Frequently Asked Questions About BHC

    What is the BHC stock forecast?

    Consensus analyst estimates put Bausch Health Companies's EPS at $4.91 for the fiscal year ending Dec 31, 2026, on revenue of $11.03B. The consensus rating from 7 analysts is Hold.

    How do analysts rate BHC stock?

    Of 7 analysts covering Bausch Health Companies, 0 rate it Strong Buy, 0 Buy, 7 Hold, 0 Sell and 0 Strong Sell, for a consensus of Hold.

    What EPS do analysts expect from BHC next year?

    For the fiscal year ending Dec 31, 2026, the consensus EPS estimate is $4.91, with estimates from $4.32 to $5.33 from 6 analysts. For the fiscal year ending Dec 31, 2027, the consensus EPS estimate is $4.34, with estimates from $4.00 to $4.77 from 6 analysts.

    What revenue do analysts expect from Bausch Health Companies next year?

    For the fiscal year ending Dec 31, 2026, the consensus revenue estimate is $11.03B, with estimates from $10.92B to $11.11B. For the fiscal year ending Dec 31, 2027, the consensus revenue estimate is $10.96B, with estimates from $10.85B to $11.14B.

    How many analysts cover BHC?

    7 analysts rate Bausch Health Companies stock, and 6 analysts estimate its EPS for the fiscal year ending Dec 31, 2026.